TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: McIntyre New AACI President, Salmon President Elect; Hubbard NCI AD; Underleider CIB Chief September 30, 1988